Get started
Author

Mary Flanagan Quinn

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
2014 · Edward Sausville, Patricia LoRusso, et al. · Cancer Chemotherapy and Pharmacology · 192
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
2010 · J E Lancet, I Gojo, et al. · Leukemia · 155
Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors
2012 · Patricia M. LoRusso, Martin J. Edelman, et al. · Journal of Clinical Oncology · 98
PDF
Phase I trial of the triplet M6620 (formerly VX970) + veliparib + cisplatin in patients with advanced solid tumors.
2018 · Geraldine Helen O'Sullivan Coyne, Khanh Tu Do, et al. · Journal of Clinical Oncology · 12
Phase I study of indenoisoquinolines LMP776 in adults with relapsed solid tumors and lymphomas.
2017 · Geraldine Helen O'Sullivan Coyne, Shivaani Kummar, et al. · Journal of Clinical Oncology · 11
Safety, tolerability, and antitumor activity of once-daily Wee-1 inhibitor AZD1775.
2018 · Naoko Takebe, Geraldine Helen O'Sullivan Coyne, et al. · Journal of Clinical Oncology · 8
Phase I pilot study of RRx-001 + nivolumab in patients with traditionally non-checkpoint inhibitor-responsive cancers (PRIMETIME).
2020 · Corey Carter, Scott Caroen, et al. · Journal of Clinical Oncology · 5
An explorary analysis of a COVID-truncated REPLATINUM phase 3 trial in SCLC.
2021 · Alberto Chiappori, Mary J. Fidler, et al. · Journal of Clinical Oncology · 2
Phase I study of recombinant interleukin-15 in combination with checkpoint inhibitors nivolumab and ipilimumab in subjects with refractory cancers.
2018 · Geraldine Helen O'Sullivan Coyne, Kevin Conlon, et al. · Journal of Clinical Oncology · 2
PARP Inhibition to Enhance Response to Chemotherapy
2018 · Naoko Takebe, Mary Quinn, et al. · Elsevier eBooks · 2
Phase I study (PAYLOAD) of RRx-001 + irinotecan in patients with advanced solid malignancies.
2020 · Edward Jae-Hoon Kim, Corey Allan Carter, et al. · Journal of Clinical Oncology · 1
Phase I trial of z-endoxifen with estrogen receptor imaging in adults with advanced hormone receptor–positive solid tumors including desmoid and gynecologic tumors.
2018 · Naoko Takebe, Geraldine Helen O'Sullivan Coyne, et al. · Journal of Clinical Oncology · 1
Phase I study of repetitive high-dose topotecan (T) carboplatin (C) and paclitaxel (P) in previously untreated ovarian cancer
1999 · D. Rischin, M. Prince, et al. · European Journal of Cancer · 1
Correlation of decreased expression of PD-L1 on circulating tumor cells and clinical benefit in SCLC Patients treated with RRx-001, a CD47 downregulator, in a phase II trial.
2020 · Corey Carter, Yusuke Tomita, et al. · Journal of Clinical Oncology
Phase I trial of the triplet veliparib + VX-970 + cisplatin in patients with advanced solid tumors.
2017 · Geraldine Helen O'Sullivan Coyne, Shivaani Kummar, et al. · Journal of Clinical Oncology
5012 POSTER Durable clinical responses with autologous dendritic cells pulsed with MUC1: a phase II trial in ovarian carcinoma patients
2007 · P.L. Mitchell, B. Loveland, et al. · European Journal of Cancer Supplements
Works count: 16
Citation count: 490
H-index: 6
I10-index: 5
Year
Topic
Type